EXHIBIT 1 JOINT FILING AGREEMENTNorthwest Biotherapeutics Inc • May 25th, 2004 • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that the Amendment No. 4 to Schedule 13G to which this Joint Filing Statement is being filed as an exhibit shall be a joint statement filed on behalf of each of the undersigned.
